Related Experiment Video
Updated: Dec 11, 2025

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
Interaction of non-coding RNAs and Hippo signaling: Implications for tumorigenesis
Can Liu1, Yangge Wu1, Jian Ma1
1Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China; Cancer Research Institute, School of Basic Medical Science, NHC Key Laboratory of Carcinogenesis, Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Central South University, Changsha, China; Hunan Key Laboratory of Nonresolving Inflammation and Cancer, The Third Xiangya Hospital, Central South University, Changsha, China.
Abstract:
Hippo signaling is an evolutionarily conserved pathway that controls organ size by regulating cell proliferation, apoptosis, and stem cell self-renewal by "turning off" or "turning on" the kinase cascade chain reaction to manipulate the expression of downstream genes. Dysregulation of the Hippo pathway contributes to cancer development and metastasis. Emerging evidence has revealed new insights into tumorigenesis through the interplay between the Hippo pathway and non-coding RNAs (ncRNAs), especially microRNA, long non-coding RNA and circular RNA. Here, we reviewed the interactions between the Hippo pathway and ncRNAs and their implication for a variety of tumor-promoting or tumor-repressing effects. These interactions have the potential to serve as cancer biomarkers and therapeutic targets in clinical applications.
Insights
The Hippo signaling pathway regulates organ size and is crucial in cancer. Its interaction with non-coding RNAs (ncRNAs) offers potential cancer biomarkers and therapeutic targets.
Area of Science:
- Cell Biology
- Molecular Oncology
- Genetics
Background:
- The Hippo signaling pathway is a conserved regulator of organ size, controlling cell proliferation, apoptosis, and stem cell renewal.
- Aberrant Hippo pathway activity is implicated in the development and metastasis of various cancers.
- Non-coding RNAs (ncRNAs), including microRNAs, long non-coding RNAs, and circular RNAs, are increasingly recognized for their roles in tumorigenesis.
Purpose of the Study:
- To review the intricate interactions between the Hippo signaling pathway and ncRNAs.
- To elucidate the implications of these interactions in cancer development and progression.
- To explore the potential of these interactions as cancer biomarkers and therapeutic targets.
Main Methods:
- Literature review of studies investigating Hippo pathway and ncRNA crosstalk.
- Analysis of research on the functional roles of ncRNAs in Hippo pathway-mediated tumorigenesis.
- Synthesis of evidence regarding clinical applications of Hippo pathway-ncRNA interactions.
Main Results:
- The Hippo pathway and ncRNAs exhibit complex regulatory crosstalk influencing cancer.
- Specific ncRNAs can act as tumor suppressors or oncogenes by modulating Hippo pathway components.
- These interactions contribute to diverse tumor-promoting or tumor-repressing effects.
Conclusions:
- The interplay between the Hippo pathway and ncRNAs is a critical factor in tumorigenesis.
- Understanding these interactions provides novel insights into cancer mechanisms.
- Hippo pathway-ncRNA networks represent promising avenues for developing cancer biomarkers and therapeutic strategies.
Related Concept Videos
Experimental RNAi
lncRNA - Long Non-coding RNAs
Hedgehog Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
piRNA - Piwi-interacting RNAs
MicroRNAs

